Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E G Engleman

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Clinical Immunology and Immunopathology|August 1, 1989
A subset of human rosetted lymphocytes contains previously unidentified histamineM M Khan, D M Fishwild, K L Melmon, et al.
Immunology|July 1, 1995
Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cellsF F Fagnoni, M Takamizawa, W R Godfrey, et al.
Immunological Reviews|January 1, 1983
Correlation of functional properties of human lymphoid cell subsets and surface marker phenotypes using multiparameter analysis and flow cytometryL L Lanier, E G Engleman, P Gatenby, et al.
Cell|June 5, 1987
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membraneB S Stein, S D Gowda, J D Lifson, et al.
American Journal of Clinical Pathology|December 1, 1986
The immunohistology of the persistent generalized lymphadenopathy syndrome (PGL)C F Garcia, J D Lifson, E G Engleman, et al.
Arthritis and Rheumatism|November 1, 1981
Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune diseaseE G Engleman, G Sonnenfeld, M Dauphinee, et al.
Journal of Immunological Methods|May 11, 1984
Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridomaS K Foung, S Perkins, A Raubitschek, et al.
Angiogenesis|August 29, 2002
Statin-AE: a novel angiostatin-endostatin fusion protein with enhanced antiangiogenic and antitumor activityF A Scappaticci, A Contreras, R Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2001
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapyL Fong, Y Hou, A Rivas, et al.
The Journal of Investigative Dermatology|November 1, 1982
Use of the fluorescence-activated cell sorter to quantitate and enrich for subpopulations of human skin cellsV B Morhenn, C J Benike, D J Charron, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Clinical Immunology and Immunopathology|August 1, 1989
A subset of human rosetted lymphocytes contains previously unidentified histamineM M Khan, D M Fishwild, K L Melmon, et al.
Immunology|July 1, 1995
Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cellsF F Fagnoni, M Takamizawa, W R Godfrey, et al.
Immunological Reviews|January 1, 1983
Correlation of functional properties of human lymphoid cell subsets and surface marker phenotypes using multiparameter analysis and flow cytometryL L Lanier, E G Engleman, P Gatenby, et al.
Cell|June 5, 1987
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membraneB S Stein, S D Gowda, J D Lifson, et al.
American Journal of Clinical Pathology|December 1, 1986
The immunohistology of the persistent generalized lymphadenopathy syndrome (PGL)C F Garcia, J D Lifson, E G Engleman, et al.
Arthritis and Rheumatism|November 1, 1981
Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune diseaseE G Engleman, G Sonnenfeld, M Dauphinee, et al.
Journal of Immunological Methods|May 11, 1984
Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridomaS K Foung, S Perkins, A Raubitschek, et al.
Angiogenesis|August 29, 2002
Statin-AE: a novel angiostatin-endostatin fusion protein with enhanced antiangiogenic and antitumor activityF A Scappaticci, A Contreras, R Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2001
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapyL Fong, Y Hou, A Rivas, et al.
The Journal of Investigative Dermatology|November 1, 1982
Use of the fluorescence-activated cell sorter to quantitate and enrich for subpopulations of human skin cellsV B Morhenn, C J Benike, D J Charron, et al.
Pageof 20